Evidence map›Paper›PMID 35686079›Full record

ArticleFrontiers in psychology2022

Cognitive and Neuropsychiatric Features of COVID-19 Patients After Hospital Dismission: An Italian Sample.

Veronica Cian, Alessandro De Laurenzis, Chiara Siri, Anna Gusmeroli, Margherita Canesi

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in psychology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05143320 (Cognitive and Neuropsychiatric Features of COVID-19 Patients After Hospital Dismission), which is not on this map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05143320 completednot on this map

Cognitive and Neuropsychiatric Features of COVID-19 Patients After Hospital Dismission: an Italian Sample.

TypeobservationalSponsorOspedale Generale Di Zona Moriggia-PelasciniRan2021 to 2021Enrolled29ConditionsCOVID-19, Sars-CoV-2 Infection
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Veronica CianParkinson's Disease Department, Moriggia-Pelascini Hospital, Gravedona ed Uniti, Italy.
Alessandro De LaurenzisParkinson's Disease Department, Moriggia-Pelascini Hospital, Gravedona ed Uniti, Italy.
Chiara SiriParkinson's Disease Department, Moriggia-Pelascini Hospital, Gravedona ed Uniti, Italy.
Anna GusmeroliParkinson's Disease Department, Moriggia-Pelascini Hospital, Gravedona ed Uniti, Italy.
Margherita CanesiParkinson's Disease Department, Moriggia-Pelascini Hospital, Gravedona ed Uniti, Italy.
Moriggia Pelascini Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Recent studies suggest cognitive, emotional, and behavioral impairments occur in patients after SARS-CoV-2 infection. However, studies are limited to case reports or case series and, to our knowledge, few of them have control groups. This study aims to assess the prevalence of neuropsychological and neuropsychiatric impairment in patients after hospitalization. Methods: We enrolled 29 COVID+ patients (M/F: 17/12; age 58.41 ± 10.00 years; education 11.07 ± 3.77 years, 2 left handers) who needed hospitalization but no IC, about 20 days post-dismission, and 29 COVID- healthy matched controls. Neuropsychological and neuropsychiatric assessments were conducted Results: Among COVID+, 62% had at least one pathological test (vs. 13% in COVID-; Conclusions: Patients COVID+ assessed by teleneuropsychology showed a vulnerability in some memory and executive functions (working memory, learning, delayed recall, and recognition). Intriguingly, anxiety was higher in the control group. Our findings therefore confirm the impact of COVID-19 on cognition even in patients who did not need IC. Follow-up is needed to evaluate the evolution of COVID-19-related cognitive deficit. Clinical Trial Registration: [ClinicalTrials.gov], identifier [NCT05143320].

Indexed as

cognitionCOVID-19executive functionsmemoryteleneuropsychology

Identifiers

PMID35686079
PMCPMC9173000
OpenAlexW4281388257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.